These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8877078)

  • 1. Attenuation of regional myocardial stunning by felodipine.
    Rose J; Heusch G
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):347-9. PubMed ID: 8877078
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.
    Bernstein EA; Eberli FR; Silverman AM; Horowitz GL; Apstein CS
    Cardiovasc Drugs Ther; 1996 May; 10(2):167-78. PubMed ID: 8842509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury.
    Bolli R; Triana F; Jeroudi MO
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in myocardial ischemia/reperfusion--update 2012.
    Kleinbongard P; Baars T; Heusch G
    Wien Med Wochenschr; 2012 Jul; 162(13-14):302-10. PubMed ID: 22695811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic oral supplementation with alpha-tocopherol on myocardial stunning in the dog.
    Forrat R; de Lorgeril M; Hadour G; Sebbag L; Delaye J; Ferrera R
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):457-62. PubMed ID: 9156354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
    Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
    Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning.
    Ross S; Muñoz H; Piriou V; Ryder WA; Foëx P
    Acta Anaesthesiol Scand; 1998 Jan; 42(1):23-31. PubMed ID: 9580055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and stunned myocardium.
    Mazer CD
    J Card Surg; 1993 Mar; 8(2 Suppl):329-31. PubMed ID: 8461526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect of felodipine, a new calcium antagonist].
    Inoue T; Omosu M; Hayashi S; Sakaguchi S; Nakao K; Inukai T; Odagiri N; Ono T
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):453-62. PubMed ID: 1464403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers (felodipine) and pediatric essential hypertension.
    Kotchen TA; Mansour G; Mansour AJ
    Curr Hypertens Rep; 2003 Dec; 5(6):484-5. PubMed ID: 14594568
    [No Abstract]   [Full Text] [Related]  

  • 13. Felodipine protects human atrial muscle from hypoxia-reoxygenation dysfunction: a force-frequency relationship study in an in vitro model of stunning.
    Iwashiro K; Criniti A; Sinatra R; Dawodu AA; d'Amati G; Monti F; Pannarale L; Bernucci P; Brancaccio GL; Vetuschi A; Gaudio E; Gallo P; Puddu PE
    Int J Cardiol; 1997 Nov; 62(2):107-32. PubMed ID: 9431863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of myocardial stunning.
    Heusch G
    Basic Res Cardiol; 1997; 92 Suppl 2():30-1. PubMed ID: 9457366
    [No Abstract]   [Full Text] [Related]  

  • 15. Stunned myocardium and the attenuation of stunning by calcium antagonists.
    Ehring T; Heusch G
    Am J Cardiol; 1995 Apr; 75(13):61E-67E. PubMed ID: 7726127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium channels blocker felodipin in the treatment of patients with arterial hypertension and chronic cardial failure with preserved cardiac output].
    Drapkina OM; Ashikhmin IaI
    Ter Arkh; 2011; 83(12):26-34. PubMed ID: 22416441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
    Koenig W; Höher M
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension].
    Runikhina NK; Tkacheva ON
    Kardiologiia; 2008; 48(9):50-2. PubMed ID: 18991821
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease.
    Kal JE; Spaan JA; van Wezel HB
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):225-33. PubMed ID: 11791008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adenosine on myocardial 'stunning' in the dog.
    Sekili S; Jeroudi MO; Tang XL; Zughaib M; Sun JZ; Bolli R
    Circ Res; 1995 Jan; 76(1):82-94. PubMed ID: 8001281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.